Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) at last check was buoying at $27.08 on current market day with a rise of 17.23% from its closing price on previous day.
Considering stock’s 52-week price range provides that TNXP hit a high price of $672.00 and saw its price falling to a low level of $6.76 during that period. Over a period of past 1-month, stock came adding 70.74% in its value.
In contrast, when we review TNXP stock’s current outlook then short term indicators are assigning it an average of Hold, while medium term indicators are categorizing the stock at an average of 50% Sell. Long term indicators are suggesting an average of 50% Buy for it.
According to ratings assigned by 5 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 1 of them are recommending Tonix Pharmaceuticals Holding Corp (TNXP) as a Hold, while 4 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.
Digging deeper we become aware of the PEG ratio of the TNXP stock which is currently positioned at 0. It further provides that stock’s current price level is 42.74% away from its 20-day simple moving average and is 45.24% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 75.47 while volatility remained at 10.13% over the past week which changes to 9.01% when measuring it over the past month. Beta is valued at 1.75, while measure of average true range or ATR is currently at 2.20.
The percentage of outstanding shares held by the insiders is 0.00% while it is 5.31% for the institutional holders. Subtraction of -17.89% by stock’s current price to its year-to-date value in today’s trading is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
